TREA

97008640 - POWERED BY BIOHM

Follow

Information

  • Trademark
  • 97008640
  • Serial Number
    97008640
  • Filing Date
    September 02, 2021
    3 years ago
  • Transaction Date
    October 15, 2024
    4 months ago
  • Status Date
    October 14, 2024
    4 months ago
  • Published for Opposition Date
    August 16, 2022
    2 years ago
  • Location Date
    October 14, 2024
    4 months ago
  • Status Code
    616
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    DAWE III, BILL
  • Attorney Docket Number
    36133-0026
    Attorney Name
    Brian E. Turung
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
4
Mark Identification
POWERED BY BIOHM
Case File Statements
  • GS0051: Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's Disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's Disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's Disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibers in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's Disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for medical use, namely, probiotics, for improving the physical well-being of humans, namely, reducing inflammation and pain; dietary supplements for medical use and baby food containing microorganisms, namely, metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal extracts sold as a component ingredient of nutritional supplments and vitamins and bacterial probiotic supplements, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Disease, ulcerative colitis and irritable bowel syndrome; beverages containing probiotic compositions for use as a nutritional supplement; food supplements containing probiotic compositions; human food supplements containing probiotic compositions; animal food products containing probiotic compositions, namely, probiotic animal feed; dietary supplement drink mixes, namely, probiotic compositions in the form of mixes to added to beverages; dietary supplements in the nature of probiotic compositions for mixing with cereal; medical specimens collection kits for the collection of body fluids comprised of swabs for medical purposes, a sealable collection container and sample bag; medical specimens collection kits for the collection of body fluids comprised of swabs for medical purposes, a sealable collection container, sample bag, mailer envelope, ID sticker, and swab applicator; diagnostic biological testing kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic genetic testing kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic microbiota testing kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; medical specimen collection kits for the collection of body fluids comprised of medical specimen bags and cups
Case File Event Statements
  • 10/15/2021 - 3 years ago
    1 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/10/2022 - 3 years ago
    2 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/12/2022 - 3 years ago
    4 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/12/2022 - 3 years ago
    5 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/12/2022 - 2 years ago
    6 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/12/2022 - 3 years ago
    3 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/12/2022 - 2 years ago
    7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/13/2022 - 2 years ago
    8 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/14/2022 - 2 years ago
    9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/27/2022 - 2 years ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/16/2022 - 2 years ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/16/2022 - 2 years ago
    12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/11/2022 - 2 years ago
    13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/7/2023 - a year ago
    17 - SOU EXTENSION 1 FILED Type: EXT1
  • 4/14/2023 - a year ago
    15 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 4/19/2023 - a year ago
    16 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 4/20/2023 - a year ago
    18 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 4/21/2023 - a year ago
    19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/7/2023 - a year ago
    14 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/11/2023 - a year ago
    20 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/11/2023 - a year ago
    21 - SOU EXTENSION 2 FILED Type: EXT2
  • 10/11/2023 - a year ago
    22 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 10/13/2023 - a year ago
    23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/9/2024 - 11 months ago
    25 - SOU EXTENSION 3 FILED Type: EXT3
  • 4/9/2024 - 11 months ago
    26 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 4/9/2024 - 11 months ago
    24 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/10/2024 - 11 months ago
    27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/14/2024 - 4 months ago
    28 - TEAS PETITION TO REVIVE RECEIVED Type: PROA
  • 10/14/2024 - 4 months ago
    30 - NOTICE OF REVIVAL - E-MAILED Type: NREV
  • 10/14/2024 - 4 months ago
    29 - PETITION TO REVIVE-GRANTED Type: PETG
  • 10/14/2024 - 4 months ago
    31 - SOU EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX